Last update 02 May 2024
NovelMed Therapeutics, Inc.

NovelMed Therapeutics, Inc.

Private Company|
2003|
Ohio, United States
|
< 10
|

Overview

Basic Info

Introduction
NovelMed Therapeutics, Inc. is a privately held American company based in Cleveland, OH, providing pharmaceutical research and development services. Established in 2003, the company focuses on being a clinical-stage biopharmaceutical entity with a commitment to innovation and the development of novel biologics for treating rare (orphan) diseases. The primary objective of NovelMed Therapeutics is to create an alternative pathway-specific drug capable of treating a diverse array of rare diseases while ensuring affordability for patients. The company has built a robust portfolio of intellectual property with broad applications covering both rare and common diseases. This includes the use of NM8074 as a potential treatment for complement-mediated disorders associated with the uncontrolled activation of the alternative pathway (AP). Within its antibody platform, NovelMed's portfolio also encompasses humanized antibodies targeting C3b and Factor P (Properdin), effectively blocking the formation of C3/C5 convertases.

Tags

Hemic and Lymphatic Diseases
Congenital Disorders
Eye Diseases
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Monoclonal antibody5

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 Jun 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Preclinical
Phase 1 Clinical
2
1
Phase 2 Clinical
Other
7
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free